Skip to main content
PMC home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2016 Mar 5;39(4):438–442. doi: 10.1080/00313020701444507

Epidemiology of Clostridium difficile infection in a large teaching hospital in Singapore

Tse Hsien Koh *,*, Ai Ling Tan *, Mee Lee Tan *, Grace Wang *, Keang Peng Song †,‡
PMCID: PMC7130798  PMID: 17676487

Abstract

Aims

We undertook this study to define the incidence of toxigenic Clostridium difficile in our hospital and to characterise the isolates.

Methods

All unformed stool was tested for the presence of Toxin A (TcdA) and Toxin B (TcdB), and cultured for C. difficile. Culture filtrates were also tested for TcdA and TcdB. Detection of tcdA and tcdB genes was carried out for A2B+ strains by polymerase chain reaction (PCR).The minimum inhibitory concentrations (MICs) of metronidazole, vancomycin and clindamycin for all isolates were tested using the Etest. PCR ribotyping was carried out on all isolates.

Results

The incidence of Clostridium difficile associated disease (CDAD) was 3.2 cases per 1000 admissions or discharges and 53.8 cases per 100000 patient days. Most cases occurred in renal and haematology patients. CDAD was more common in patients aged over 50 years and of male gender. The Indian population was under-represented. Fourteen (11.8%) isolates were A-B+.

All strains were susceptible to metronidazole but one strain showed intermediate resistance to vancomycin. Only 12.8% of the isolates were susceptible to clindamycin. Thirty-five isolates had PCR ribotype A, of which 29 (83%) had a clindamycin MIC >256 mg/L. Thirty-three had PCR ribotype B, of which only one (3%) had a clindamycin MIC >256 mg/L. The 14 A-B+ strains were all PCR ribotype C, and had a range of MICs for clindamycin from 2 to >256 mg/L. Conclusions: The incidence of CDAD in our hospital is relatively low. Isolates remain susceptible to metronidazole and vancomycin.

Key words: PCR ribotyping; minimum inhibitory concentration, TcdA; TcdB, A-B+

References

  • 1.Lyerly D.M., Lockwood D.E., Richardson S.H., Wilkins T.D. Biological activities of toxins A and B of Clostridium difficile. Infect Immunol. 1982;35:1147–1150. doi: 10.1128/iai.35.3.1147-1150.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Lyerly D.M., Saum K.E., MacDonald D.K., Wilkins T.D. Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immunol. 1985;47:349–352. doi: 10.1128/iai.47.2.349-352.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kumarasinghe G., Lim Y.S., Chow C., Bassett D.C. Prevalence of bacterial agents of diarrhoeal disease at the National University Hospital, Singapore and their resistance to antimicrobial agents. Trop Geogr Med. 1992;44:229–232. [PubMed] [Google Scholar]
  • 4.Goh K.T., Cutter J., Heng B.H., et al. Epidemiology and control of SARS in Singapore. Ann Acad Med Singapore. 2006;35:301–316. [PubMed] [Google Scholar]
  • 5.Dowell V.R., Jr., Lombard G.L., Thompson F.S., Armfield A.Y. Media for isolation, characterization, and identification of obligately anaerobic bacteria. US Department of Health, Education, and Welfare. Atlanta: Public Health Service, Center of Disease Control, Bureau of Laboratories, Bacteriology Division, Enterobacteriology Branch. 1977:30333. [Google Scholar]
  • 6.Kato H., Kato N., Katow S., Maegawa T., Nakamura S., Lyerly D.M. Deletions in the repeating sequences of the toxin A gene of toxin Anegative, toxin B-positive Clostridium difficile strains. FEMS Microbiol Lett. 1999;175:197–203. doi: 10.1111/j.1574-6968.1999.tb13620.x. [DOI] [PubMed] [Google Scholar]
  • 7.O’Brien T.F., Stelling J.M. WHONET: removing obstacles to the full use of information about antimicrobial resistance. Diagn Microbiol Infect Dis. 1996;25:162–168. [PubMed] [Google Scholar]
  • 8.Stubbs S.L., Brazier J.S., O’Neill G.L., Duerden B.I. PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol. 1999;37:461–463. doi: 10.1128/jcm.37.2.461-463.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Loo V.G., Poirier L., Miller M.A., et al. A predominantly clonal multiinstitutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353:2442–2449. doi: 10.1056/NEJMoa051639. [DOI] [PubMed] [Google Scholar]
  • 10.Barbut F., Petit J.C. Epidemiology of Clostridium difficile-associated infections. Clin Microbiol Infect. 2001;7:405–410. doi: 10.1046/j.1198-743x.2001.00289.x. [DOI] [PubMed] [Google Scholar]
  • 11.Johnson S., Samore M.H., Farrow K.A., et al. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med. 1999;341:1645–1651. doi: 10.1056/NEJM199911253412203. [DOI] [PubMed] [Google Scholar]
  • 12.McDonald L.C. Clostridium difficile: responding to a new threat from an old enemy. Infect Control Hosp Epidemiol. 2005;26:672–675. doi: 10.1086/502600. [DOI] [PubMed] [Google Scholar]
  • 13.Karlstrom O., Fryklund B., Tullus K., Burman L.G. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile Study Group. Clin Infect Dis. 1998;26:141–145. doi: 10.1086/516277. [DOI] [PubMed] [Google Scholar]
  • 14.Noren T., Akerlund T., Back E., et al. Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county. J Clin Microbiol. 2004;42:3635–3643. doi: 10.1128/JCM.42.8.3635-3643.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Svenungsson B., Burman L.G., Jalakas-Pornull K., Lagergren A., Struwe J., Akerlund T. Epidemiology and molecular characterization of Clostridium difficile strains from patients with diarrhea: low disease incidence and evidence of limited cross-infection in a Swedish teaching hospital. J Clin Microbiol. 2003;41:4031–4037. doi: 10.1128/JCM.41.9.4031-4037.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Bouza E., Pelaez T., Alonso R., Catalan P., Munoz P., Creixems M.R. ‘Second-look’ cytotoxicity: an evaluation of culture plus cytotoxin assay of Clostridium difficile isolates in the laboratory diagnosis of CDAD. J Hosp Infect. 2001;48:233–237. doi: 10.1053/jhin.2001.1000. [DOI] [PubMed] [Google Scholar]
  • 17.Delmée M., Van Broeck J., Simon A., Janssens M., Avesani V. Laboratory diagnosis of Clostridium difficile-associated diarrhoea: a plea for culture. J Med Microbiol. 2005;54 (Pt 2):187–191. doi: 10.1099/jmm.0.45844-0. [DOI] [PubMed] [Google Scholar]
  • 18.Al Barrak A., Embil J., Dyck B., et al. An outbreak of toxin A negative, toxin B positive Clostridium difficile-associated diarrhea in a Canadian tertiary-care hospital. Can Commun Dis Rep. 1999;25:65–69. [PubMed] [Google Scholar]
  • 19.Alfa M.J., Kabani A., Lyerly D., et al. Characterization of a toxin Anegative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. J Clin Microbiol. 2000;38:2706–2714. doi: 10.1128/jcm.38.7.2706-2714.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.van den Berg R.J., Claas E.C., Oyib D.H., et al. Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping. J Clin Microbiol. 2004;42:1035–1041. doi: 10.1128/JCM.42.3.1035-1041.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Johnson S., Sambol S.P., Brazier J.S., et al. International typing study of toxin A-negative, toxin B-positive Clostridium difficile variants. J Clin Microbiol. 2003;41:1543–1547. doi: 10.1128/JCM.41.4.1543-1547.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Lyerly D.M., Neville L.M., Evans D.T., et al. Multicenter evaluation of the Clostridium difficile TOX A/B TEST. J Clin Microbiol. 1998;36:184–190. doi: 10.1128/jcm.36.1.184-190.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Brazier J.S., Stubbs S.L., Duerden B.I. Prevalence of toxin A negative/B positive Clostridium difficile strains. J Hosp Infect. 1999;42:248–249. [PubMed] [Google Scholar]
  • 24.Barbut F., Lalande V., Burghoffer B., Thien H.V., Grimprel E., Petit J.C. Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France. J Clin Microbiol. 2002;40:2079–2083. doi: 10.1128/JCM.40.6.2079-2083.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Pituch H., van den B.N., Van Leeuwen W., et al. Clonal dissemination of a toxin-A-negative/toxin-B-positive Clostridium difficile strain from patients with antibiotic-associated diarrhea in Poland. Clin Microbiol Infect. 2001;7:442–446. doi: 10.1046/j.1198-743x.2001.00312.x. [DOI] [PubMed] [Google Scholar]
  • 26.Barbut F., Decre D., Burghoffer B., et al. Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997. Antimicrob Agents Chemother. 1999;43:2607–2611. doi: 10.1128/aac.43.11.2607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Aspevall O., Lundberg A., Burman L.G., Akerlund T., Svenungsson B. Antimicrobial susceptibility pattern of Clostridium difficile and its relation to PCR ribotypes in a Swedish university hospital. Antimicrob Agents Chemother. 2006;50:1890–1892. doi: 10.1128/AAC.50.5.1890-1892.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Noren T., Tang-Feldman Y.J., Cohen S.H., Silva J Jr, Olcen P. Clindamycin resistant strains of Clostridium difficile isolated from cases of C. difficile associated diarrhea (CDAD) in a hospital in Sweden. Diagn Microbiol Infect Dis. 2002;42:149–151. doi: 10.1016/s0732-8893(01)00337-6. [DOI] [PubMed] [Google Scholar]
  • 29.Pelaez T., Alcala L., Alonso R., Rodriguez-Creixems M., Garcia-Lechuz J.M., Bouza E. Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin. Antimicrob Agents Chemother. 2002;46:1647–1650. doi: 10.1128/AAC.46.6.1647-1650.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Pathology are provided here courtesy of Elsevier

RESOURCES